Enzymes Market Size, Share & Trends Analysis Report By Type (Industrial, Specialty), By Product (Carbohydrase, Proteases), By Source (Microorganisms, Animals), By Region, And Segment Forecasts, 2021 - 2028
Enzymes Market Growth & Trends
The global enzymes market size is expected to reach USD 17.88 billion by 2028. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. Rising consumer awareness regarding health has resulted in the growing consumption of functional food products, which is expected to trigger product demand in the coming years.
The demand for carbohydrase is increasing due to their extensive use as an ingredient in soft drinks.Carbohydrase is categorized into amylase, xylanase, cellulose, pectinase, and lactase.
Increasing application of various types of carbohydrase in the pharmaceutical and animal feed sectors is anticipated to drive the market over the forecast period.
The U.S. is expected to continue dominating the North American market over the forecast period due to the high demand for the product from the food and beverage sector and increasing consumer awareness about health. The U.S. market is anticipated to witness notable growth on account of the extensive growth of the nutraceutical and pharmaceutical sectors in the country.
The market for enzymes is highly influenced by dominated supply from key players such as Novozymes AG, DuPont Danisco, and DSM, thus making it oligopolistic.The market has observed a rise in the demand for superior quality specialty enzymes.
As a result, raw material distributors and manufacturers have significant opportunities to provide high-quality and uniform enzymes through a reviewed supply chain.
Enzymes Market Report Highlights • By type, industrial enzymes captured the largest revenue share of over 55.0% in 2020. In the industrial enzymes segment, the food and beverages segment captured the largest share in 2020 due to the growing consumption of functional food products and surging utilization of enzymes in bakery applications • In the specialty enzymes type segment, the pharmaceutical segment held the largest revenue share of over 40.0% in 2020 due to the growing inclusion of enzymes for key applications such as diagnosing diseases, promoting wound healing, and killing disease-causing microorganisms • By source, the microorganisms segment held the largest revenue share of over 80.0% in 2020 owing to the increasing demand for fungi-based enzymes in numerous end-use industries • North America held the largest revenue share in 2020 due to the strong presence of various end-use companies in the food and beverage, laundry detergent, pharmaceuticals, and personal care and cosmetics industries, along with high scope for research & development activities in developed countries
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Single-use Bioprocessing System Market 2022-2026 The analyst has been monitoring the single-use bioprocessing system market and it is poised to grow by $ 10.60 bn during 2022-2026, accelerating at a CAGR of 17.33% during the forecast period. Our report on the single-use bioprocessing system market provides a holistic...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Ricinoleic Acid Market 2022-2026 The analyst has been monitoring the ricinoleic acid market and it is poised to grow by $ 90.64 mn during 2022-2026, accelerating at a CAGR of 4.52% during the forecast period. Our report on the ricinoleic acid market provides a holistic analysis, market size and forecast, trends,...
The global seaweed market reached a value of US$ 6.73 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 12.85 Billion by 2027, exhibiting a CAGR of 11.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
New Drug Approvals and Their Contract Manufacture - 2022 Edition Summary This report is the 12th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance.New Drug Approvals and Their Contract Manufacture (formerly called CMO Scorecard)...
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2022 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering...
Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangitis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Cyclin Dependent Kinase 4 - Drugs In Development,...
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) pipeline Target constitutes close to 35 molecules....
Cancer
Hepatitis
Pharmaceutical
World
Prescription Drug Sales
Cancer Mortality
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.